NC
CC icon

North Capital’s Chemours CC Stock Holding History

North Capital’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$16 – 183
2025
Q3 		$16 Buy
+1
New +$15 ﹤0.01% 725

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

North Capital's CC Position: Q4 2025 in Review

North Capital sold out of Chemours (CC) in Q4 2025, closing a stake of 1 share — an estimated $16 sold.

North Capital first reported a position in CC in Q3 2025 and held it in 1 quarter. The position peaked at $16 in Q3 2025. 435 funds tracked by Wall St. Rank hold CC as of Q4 2025.

  • North Capital reported no remaining Chemours position as of Q4 2025 after selling out during the quarter.
  • North Capital sold 1 Chemours share in Q4 2025, an estimated $16.
  • North Capital first reported a position in Chemours in Q3 2025 and held it in 1 quarter.
  • North Capital's Chemours position peaked at $16 in Q3 2025.
  • 435 funds tracked by Wall St. Rank held Chemours as of Q4 2025.

Based on North Capital's 13F filing for Q4 2025, filed 18 Feb 2026.